Velentium vs Sagentia Innovation: full comparison for 2026
Quick verdict
Velentium (4.5/5) edges ahead of Sagentia Innovation (4.1/5) overall. Velentium is the better choice for implantables and FDA cybersecurity submissions. Sagentia Innovation is the stronger option for surgical robotics and combination products. The right choice depends on your project size, budget, and required tech stack.
Velentium vs Sagentia Innovation: head-to-head summary
| Criterion | Velentium | Sagentia Innovation |
|---|---|---|
| Founded | 2012 | 1986 |
| HQ | Katy, TX, USA | Harston, Cambridge, UK |
| Team size | 51–250 | 650+ (Science Group) |
| Rating | 4.5 / 5 | 4.1 / 5 |
| Primary differentiator | Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation | Medical development backed by a listed science group that also runs a regulatory consultancy |
| Pricing model | Fixed project, time and materials, manufacturing contract | Time and materials, fixed project |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, RTOS, BLE | Embedded C/C++, Robotics, Mechanical simulation |
| Industries served | Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring | Surgical & robotics, Drug delivery, Diagnostics & lab devices |
Velentium vs Sagentia Innovation: overview
Velentium
Velentium was founded in 2012 and is based in Katy, near Houston, Texas. It designs, develops and manufactures active medical devices, including implantables and their programmers, and offers systems engineering, firmware, software, cybersecurity and CGMP manufacturing. Great Point Partners completed a growth recapitalization in 2021, the company sold its oil and gas division in 2023 to focus fully on medtech, and it took $15M in growth financing from Trinity Capital in 2024. Headcount estimates range from 51 to 250.
Sagentia Innovation
Sagentia Innovation is owned by Science Group plc, which is listed on the London Stock Exchange's AIM market. Its roots go back to 1986; the current business was formed in 2021 from Sagentia, OTM Consulting and Oakland Innovation. It is based at Harston Mill near Cambridge, with R&D facilities in Cambridge and Epsom, and its medical work covers devices, combination products and surgical robotics. Science Group employs more than 650 people across all its businesses.
Services and capabilities: Velentium vs Sagentia Innovation
| Capability | Velentium | Sagentia Innovation |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✓ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✗ | ✓ |
| Device cybersecurity | ✓ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✓ | ✗ |
Tech stack comparison: Velentium vs Sagentia Innovation
| Framework / platform | Velentium | Sagentia Innovation |
|---|---|---|
| Embedded C/C++ | ✓ | ✓ |
| Embedded Linux | N/A | N/A |
| RTOS | ✓ | N/A |
| BLE | ✓ | N/A |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | ✓ | N/A |
| ISO 14971 | ✓ | N/A |
| ISO 13485 QMS | N/A | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Velentium vs Sagentia Innovation
| Criterion | Velentium | Sagentia Innovation |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Fixed project, Manufacturing contract, Time & materials | Consulting, Fixed project, Time & materials |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Velentium vs Sagentia Innovation
| Dimension | Velentium | Sagentia Innovation |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring | Surgical & robotics, Drug delivery, Diagnostics & lab devices |
| Best use cases | Building a neurostimulator and its clinician programmer, Preparing the cybersecurity section of an FDA 510(k) or PMA | Surgical robot subsystem development, Drug-device combination product engineering |
| Typical project type | Fixed project | Consulting |
Velentium vs Sagentia Innovation: pros and cons
| Velentium | |
|---|---|
| + | Cybersecurity is a full practice here, covering threat modeling, SBOMs, testing and postmarket monitoring |
| + | Experience with active implantable devices, one of the hardest device categories to engineer and certify |
| + | Can manufacture Class II and III devices after development, reducing transfer risk |
| + | Offers training on device cybersecurity, which helps client teams keep up after hand-off |
| - | Private-equity recapitalization and debt financing mean ownership priorities may shift over time |
| - | Smaller than the large consultancies, so very broad programs may stretch the team |
| - | Industrial design and human factors are not its main strength |
| Sagentia Innovation | |
|---|---|
| + | Active surgical robotics software and hardware hiring shows current work in that area |
| + | Sister business TSG Consulting has a medical device regulatory team |
| + | Large owned R&D facilities in Cambridge and Epsom |
| + | About 30 years of medical device projects |
| - | Part of a listed group, so commercial priorities answer to public shareholders |
| - | Recent 2021 merger means the brand and teams are relatively new |
| - | Science Group headcount covers many businesses, so the medtech team size is unclear |
Who should choose Velentium?
A typical fit: building a neurostimulator and its clinician programmer.
Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation. Minimum engagement is not publicly disclosed. Works best with clients in Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring.
Who should choose Sagentia Innovation?
A typical fit: surgical robot subsystem development.
Medical development backed by a listed science group that also runs a regulatory consultancy. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & robotics, Drug delivery, Diagnostics & lab devices.
Decision matrix: Velentium vs Sagentia Innovation
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Velentium |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Velentium (Not disclosed) vs Sagentia Innovation (Not disclosed) |
| You need specialist depth in a specific vertical | Velentium |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Velentium vs Sagentia Innovation
| Use case | Velentium fit | Sagentia Innovation fit | Winner |
|---|---|---|---|
| Building a neurostimulator and its clinician programmer | Strong | Limited | Velentium |
| Preparing the cybersecurity section of an FDA 510(k) or PMA | Strong | Limited | Velentium |
| Surgical robot subsystem development | Limited | Strong | Sagentia Innovation |
| Drug-device combination product engineering | Limited | Strong | Sagentia Innovation |
Verdict: Velentium vs Sagentia Innovation
Velentium (4.5/5) is the stronger overall choice for most Medical Device Development projects. Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation.
Sagentia Innovation (4.1/5) is worth a look if you need drug-device combination product engineering. If your situation matches that, Sagentia Innovation is a competitive option.
Related comparisons
Velentium vs Sagentia Innovation FAQ
Is Velentium better than Sagentia Innovation?
Velentium (4.5/5) scores higher overall, but "better" depends on your use case. Velentium's strongest advantage: cybersecurity is a full practice here, covering threat modeling, SBOMs, testing and postmarket monitoring. Sagentia Innovation's strongest advantage: active surgical robotics software and hardware hiring shows current work in that area.
How do Velentium and Sagentia Innovation differ in pricing?
Velentium uses fixed project, time and materials, manufacturing contract pricing. Sagentia Innovation uses time and materials, fixed project pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Velentium or Sagentia Innovation?
Velentium is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Velentium and Sagentia Innovation?
Velentium's primary differentiator is: combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation. Sagentia Innovation's primary differentiator is: medical development backed by a listed science group that also runs a regulatory consultancy. They also differ in team size (51–250 vs 650+ (Science Group)), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Implantables & neuromodulation, Surgical & therapeutic devices vs Surgical & robotics, Drug delivery).
Verify all details directly with each company before making a decision.